Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2012
09/19/2012CN102670537A Trimetazidine dihydrochloride sustained release tablet and preparation method thereof
09/19/2012CN102670499A Slow-release sirolimus ophthalmic preparation
09/19/2012CN102670498A Sustained-release sirolimus ophthalmic preparation
09/19/2012CN102670494A Eye drop and preparation method and application thereof
09/19/2012CN102670453A Compositions for potentiating glutatthione
09/19/2012CN102670354A Traditional Chinese medicine filled eyeshade for treating children's myopia
09/19/2012CN102670013A Flower fragrance health care pillow
09/19/2012CN102670006A Dual-use, antibacterial and healthcare pillow towel
09/19/2012CN102669683A Application of ocean fish polypeptide in preparation of health food for alleviating eye fatigue
09/19/2012CN102669648A Health food for alleviating eye fatigue and preparation method thereof
09/19/2012CN102669354A Chinese machine tea bag for treating myopia
09/19/2012CN102210683B Application of tetrahydropyrimidine and derivatives thereof in preparing medicament for preventing and treating glaucoma
09/19/2012CN101947309B Human basic fibroblast growth factor eye drops and preparation method thereof
09/19/2012CN101904841B Phenylphthalimide analog and its application for preparing diabetic macular edema drugs
09/19/2012CN101796039B Phenylacetic acid compound
09/19/2012CN101530491B Method of preparing gardenia extract by applying membrane filtration technology
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012CA2696613C Compositions and methods for modulating endophthalmitis using fluoroquinolones
09/18/2012CA2461896C Injections for eye tissues containing drug bonded to polyethylene glycol
09/18/2012CA2383136C Obg3 globular head and uses thereof for decreasing body mass
09/13/2012WO2012122334A2 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
09/13/2012WO2012121560A2 Composition for preventing or treating hearing loss
09/13/2012WO2012121314A1 Dipyridylamine derivative
09/13/2012WO2012067427A3 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
09/13/2012US20120232140 Pharmaceutical combination of prostaglandin compound and nsaid for the treatment of glaucoma and ocular hypertension
09/13/2012US20120232139 Composition for ocular topical administration treatment ocular hypertension and glaucoma
09/13/2012US20120232130 Methods for inhibiting starvation of a cell
09/13/2012US20120232120 Amino acid amides of phenoxybutyric acid derivatives
09/13/2012US20120232119 Method for treating a keratoconjunctival disorder
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232100 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/13/2012US20120232081 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120232048 Method for modulating gpr119 g protein-coupled receptor and selected compounds
09/13/2012US20120231995 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
09/13/2012US20120231072 Thermo-responsive hydrogel compositions
09/13/2012US20120231038 Wound Healing Compositions Comprising Biocompatible Cellulose Hydrogel Membranes and Methods of Use Thereof
09/13/2012US20120231002 Treatment of vasculoproliferative conditions
09/13/2012US20120230997 Anti-factor B antibodies and their uses
09/13/2012US20120230996 Compositions And Methods For Macular Degeneration
09/13/2012US20120230985 Humanized anti-factor d antibodies and uses thereof
09/13/2012US20120230984 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds
09/13/2012US20120230982 High concentration antibody formulations
09/13/2012US20120230950 Compositions and Methods for Soft Tissue Augmentation
09/13/2012CA2829187A1 Dipyridylamine derivative
09/12/2012EP2497766A1 A crystalline form of bimatoprost, preparation method and use thereof
09/12/2012EP2497498A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent
09/12/2012EP2496553A1 A novel process for the preparation of prostaglandins and intermediates thereof
09/12/2012EP2496233A1 Nutritional supplements for relief of dry eye
09/12/2012EP2496214A1 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102666490A Aminopyridine compound
09/12/2012CN102665730A Ophthalmic formulation and method of manufacture thereof
09/12/2012CN102665725A Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
09/12/2012CN102665706A Antioxidant composition
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102659944A IL-18 binding proteins
09/12/2012CN102659926A Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea
09/12/2012CN102659871A Method for extracting and refining anthocyanin in black rice
09/12/2012CN102659793A Phthalocyanine silicon modified by amino ethyl groups and phenoxy groups as well as preparation method and application thereof
09/12/2012CN102657791A Chinese medicinal composition containing pale butterflybush flower and preparation method thereof
09/12/2012CN102657739A Eyesight adjusting ointment for myopia
09/12/2012CN102657705A Medicine for treating tympanitis and preparation method thereof
09/12/2012CN102657672A Veterinary compound tulathromycin nanoemulsion and preparation method thereof
09/12/2012CN102657671A Troxerutin and ligustrazine combined preparation and application thereof
09/12/2012CN102657665A Compound dehydration and diuresis medicine composition
09/12/2012CN102657660A Application of total triterpenes in preparing drugs inhibiting angiogenesis
09/12/2012CN102657656A Composition and methods for modulating a kinase cascade
09/12/2012CN102657655A Application of pyrilamine compounds to preparation of acetylcholinesterase inhibitor
09/12/2012CN102219859B Fusion protein for antagonizing angiogenesis inducible factor and application thereof
09/12/2012CN102178647B Pranlukast injection preparation
09/12/2012CN101805688B Mulberry health-care wine and preparation method thereof
09/12/2012CN101781347B Polymorphic substances of decitabine and medical compositions
09/12/2012CN101760446B Method for preparing monocyte type stem cell and application
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/11/2012US8263647 Treatment of sleep disturbances
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263614 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
09/11/2012US8263567 A lipophilic anthracycline with a pharmaceutically acceptable carrier for topical administration to a body surface and which has a higher lipophilicity than doxorubicin; valrubicin applied to mucous membranes; psoriasis; side effect reduction; not doxorubicin, daunorubicin, epirubicin or idarubicin
09/11/2012US8262054 Furnace mount
09/11/2012CA2561167C Composition of solifenacin or salt thereof for use in solid formulation
09/11/2012CA2533598C Method for modulating calcium ion-release-activated calcium ion channels
09/11/2012CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
09/07/2012WO2012118863A1 Therapies that target autoimmunity for treating glaucoma and optic neuropathy
09/07/2012WO2012118704A1 Compositions and methods for non-surgical treatment of ptosis
09/07/2012WO2012118097A1 Cell sheet having hyaluronic acid production ability and method for producing same
09/07/2012CA2827285A1 Compositions and methods for non-surgical treatment of ptosis
09/06/2012US20120225952 Non-aqueous silicone-based ophthalmic formulations
09/06/2012US20120225947 Retinal neuroprotection by ion channel blockers regulated by the sur subunit
09/06/2012US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/06/2012US20120225939 Use of Prostaglandins F2Alpha and Analogues for the Healing of Corneal and Conjunctival Lesions
09/06/2012US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists
09/06/2012US20120225930 Method of treating or retarding the development of blindness
09/06/2012US20120225920 Compositions and Methods for Non-Surgical Treatment of Ptosis
09/06/2012US20120225919 Compositions and Methods for Non-Surgical Treatment of Ptosis
09/06/2012US20120225915 Compositions and Methods of Using R(+) Pramipexole
09/06/2012US20120225906 Piperidine renin inhibitors
09/06/2012US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 531